Metraipolis › archive › dc_cb4d3391203f

Rethinking Innovation in Drugs: A Pathway to Health for All — Europe PMC PMID:38433670

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/38433670
DOI
10.1017/jme.2023.157
License (as archived)
solo-consultazione
Archived
2026-10-07T22:19:10.070Z
SHA-256 of the archived text
38331d21a919dbb10e41ba0184a119dee4df282537601f90e2d6094d14a4474c
Stable URL of this page
https://metraipolis.com/documento/dc_cb4d3391203f

How to cite

Rethinking Innovation in Drugs: A Pathway to Health for All — Europe PMC PMID:38433670 — Europe PMC (en), https://europepmc.org/article/MED/38433670 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_cb4d3391203f (Metraipolis archive dc_cb4d3391203f, sha256 38331d21a919dbb10e41ba0184a119dee4df282537601f90e2d6094d14a4474c)
BibTeX
@misc{dccb4d3391203f,
  title = {Rethinking Innovation in Drugs: A Pathway to Health for All — Europe PMC PMID:38433670},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/38433670},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_cb4d3391203f; sha256 38331d21a919dbb10e41ba0184a119dee4df282537601f90e2d6094d14a4474c},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/38433670. Agents can read the archived copy with the MCP tool read_document.